Logo

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Author(s):
Nasser Ebrahimi DaryaniNasser Ebrahimi Daryani1,*, Babak HaghpanahBabak Haghpanah2, Ali Reza SayyahAli Reza Sayyah2, Ali Asad HashtroudiAli Asad Hashtroudi2, Mohammad BashashatiMohammad Bashashati2, Parisa PoursamimiParisa Poursamimi2, Mehri NikbinMehri Nikbin2
1Tehran University of Medical Sciences, Imam Khomeini Hospital & Study Group of Interferon in Iran (SG.IFN.IR), nebrahim@sina.tums.ac.ir, Tehran, IR.Iran
2Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, IR.Iran


Hepatitis Monthly:Vol. 4, issue 7; 71-74
Article type:Research Article
How to Cite:Nasser Ebrahimi DaryaniBabak HaghpanahAli Reza SayyahAli Asad HashtroudiMohammad BashashatiParisa PoursamimiMehri Nikbinet al.The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial.Hepat Mon.4(7):71-74.

Abstract

Full Text

Full text is available in PDF

comments

Leave a comment here

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles